Guiyuan Yu

No ORCID on file · 7 papers in corpus · active 2018-2026

Study types

  • article 5
  • other 1
  • preprint 1

Condition tags

  • adenomyosis 4
  • endometriosis 3
  • dysmenorrhea 2
other 2026
Molecular biology reports ·doi:10.1007/s11033-026-11495-6

BACKGROUND: Endometriosis (EMs) is a chronic enigmatic gynecological disorder which pathogenesis have not been fully elucidated. Exosomes have been proven to participate in endometriosis. However, the role of exosomes in the pathogenesis of…

article 2024
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2024.2384471

OBJECTIVES: To observe the therapeutic efficacy of high-intensity focused ultrasound (HIFU) combined with different pharmacological treatments for adenomyosis. MATERIALS AND METHODS: A total of 126 patients with adenomyosis who underwent H…

preprint 2023
·doi:10.22541/au.167716446.61742004/v1

Objective To assess the safety and clinical efficacy of high-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone agonists (GnRH-a), hysteroscopic surgery (hysteroscopic resection of adenomyosis and endometrial a…

article 2022
·doi:10.2139/ssrn.4302568
article 2022
Medicine ·doi:10.1097/md.0000000000031615

RATIONALE: Intramural ectopic pregnancy (IMP) is a rare ectopic pregnancy with an unclear etiology, and standard treatment guidelines currently remain unclear. The main treatment option is local excision of IMP via laparoscopy or laparotomy…

article 2021
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2021.1967467

OBJECTIVE: To investigate the clinical effect of high intensity focused ultrasound (HIFU) ablation combined with gonadotropin-releasing hormone agonist (GnRH-a) and levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of …

article 2018
Anti-cancer agents in medicinal chemistry ·doi:10.2174/1871520618666180108100211

BACKGROUND/OBJECTIVE: Forkhead Box M1 (FOXM1) is frequently activated in tumors. We studied the expression and the possible mechanism of FOXM1 and evaluated the effects of thiostrepton in an endometriotic rat model. METHODS AND MATERIAL: Th…